Administrative litigation on unfair reimbursement price reduction

Published: 2003-01-23 07:00:00

Updated: 2003-01-23 07:00:00

Pharmaceutical business sources say that the third-round administrative litigation designed to invalidate some items for which reduction in reimbursement price was unilaterally made by the government, will be first examined by Seoul District Court from January 24.

The administrative litigation...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK